-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on AC Immune, Maintains $8 Price Target

Benzinga·08/05/2026 20:06:20
Listen to the news
BTIG analyst Thomas Shrader reiterates AC Immune (NASDAQ:ACIU) with a Buy and maintains $8 price target.